Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes

Victor M. Lu, Krishnan Ravindran, Christopher S. Graffeo, Avital Perry, Jamie J. Van Gompel, David J. Daniels, Michael J. Link

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences